Johanna Holldack

A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma

Hartmut Link, MA Boogaerts, Carella Am et al. · Blood · 1992 · 92 citations · Full text

A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer

Nicholas M. Donin, Karim Chamie, Andrew T. Lenis et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 41 citations

Surgical Oncology, Urology, Genitourinary Cancer +7

Treatment Trial with Recombinant Human Erythropoietin in Children with Congenital Hypoplastic Anemia

C. Niemeyer, E. Baumgarten, Johanna Holldack et al. · Contributions to nephrology · 2015 · 33 citations

Treatment Trial, Pediatric Hematology, Hematology +5

Toll-like receptors as therapeutic targets for cancer

Johanna Holldack · Drug Discovery Today · 2013 · 26 citations

Toll-like Receptors, Cancer Immunosurveillance, Immunology +3

Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemia

Christa Fonatsch, B. Stollmann, Johanna Holldack et al. · Cancer Genetics and Cytogenetics · 1987 · 25 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +4